These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4953989)

  • 21. Antimalarial dosing regimens and drug resistance.
    Barnes KI; Watkins WM; White NJ
    Trends Parasitol; 2008 Mar; 24(3):127-34. PubMed ID: 18262470
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chloroquine and dihydroquinine. In vitro studies by their antimalarial effect upon Plasmodium knowlesi.
    Polet H; Barr CF
    J Pharmacol Exp Ther; 1968 Dec; 164(2):380-6. PubMed ID: 4972437
    [No Abstract]   [Full Text] [Related]  

  • 23. Repository drugs. V. 4',4'''-[p-phenylenebis(methylidyneimino-p-phenylenesulfonyl)]bisacetanilide (PSBA) and related 4',4'''-[bis(imino-p-phenylenesulfonyl)]bisanilides, a novel class of long-acting antimalarial and antileprotic agents.
    Elslager EF; Phillips AA; Worth DF
    J Med Chem; 1969 May; 12(3):363-7. PubMed ID: 4977944
    [No Abstract]   [Full Text] [Related]  

  • 24. [Action of nitroquine on tissue schizonts of Plasmodium cynomolgi].
    Hu YM; Wang XX; Deng BZ; Liu FA; Zhu QP; Kuang MS
    Zhongguo Yao Li Xue Bao; 1986 Jan; 7(1):78-81. PubMed ID: 2945393
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the antimalarial effects of RC-12 and WR 14,997 on the development of Plasmodium cynomolgi in mosquitoes and Rhesus monkeys.
    Omar MS; Collins WE
    Am J Trop Med Hyg; 1974 May; 23(3):339-49. PubMed ID: 4207342
    [No Abstract]   [Full Text] [Related]  

  • 26. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The design of original antimalarial drugs. An example of phospholipid metabolism.
    Vial HJ; Ancelin ML; Elabbadi N; Gumila C; Bonnet H; Jeong YH; Philippot J; Calas M; Portefaix P; Piquet G
    Parassitologia; 1993 Jul; 35 Suppl():125-7. PubMed ID: 8233602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimalarial effect of B.663 in mice infected with Plasmodium berghei.
    Sheagren JN
    J Parasitol; 1968 Dec; 54(6):1250-1. PubMed ID: 5757702
    [No Abstract]   [Full Text] [Related]  

  • 29. Malaria. Signs of drug resistance rattle experts, trigger bold plan.
    Enserink M
    Science; 2008 Dec; 322(5909):1776. PubMed ID: 19095911
    [No Abstract]   [Full Text] [Related]  

  • 30. New adamantane-based spiro 1,2,4-trioxanes orally effective against rodent and simian malaria.
    Singh C; Kanchan R; Sharma U; Puri SK
    J Med Chem; 2007 Feb; 50(3):521-7. PubMed ID: 17266204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel molecular targets for antimalarial chemotherapy.
    Jana S; Paliwal J
    Int J Antimicrob Agents; 2007 Jul; 30(1):4-10. PubMed ID: 17339102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rational approach to the treatment of malaria.
    Valecha N; Srivastava A; Sharma VP
    Natl Med J India; 1994; 7(6):281-7. PubMed ID: 7841881
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis and biological activity of some di(nitrothienyl)- and di(acetylaminothienyl)sulfones.
    Ronsisvalle G; Vittorio F; Pappalardo MS
    Farmaco Sci; 1983 Nov; 38(11):877-83. PubMed ID: 6360709
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antimalarial efficacy of MMV390048, an inhibitor of
    Paquet T; Le Manach C; Cabrera DG; Younis Y; Henrich PP; Abraham TS; Lee MCS; Basak R; Ghidelli-Disse S; Lafuente-Monasterio MJ; Bantscheff M; Ruecker A; Blagborough AM; Zakutansky SE; Zeeman AM; White KL; Shackleford DM; Mannila J; Morizzi J; Scheurer C; Angulo-Barturen I; Martínez MS; Ferrer S; Sanz LM; Gamo FJ; Reader J; Botha M; Dechering KJ; Sauerwein RW; Tungtaeng A; Vanachayangkul P; Lim CS; Burrows J; Witty MJ; Marsh KC; Bodenreider C; Rochford R; Solapure SM; Jiménez-Díaz MB; Wittlin S; Charman SA; Donini C; Campo B; Birkholtz LM; Hanson KK; Drewes G; Kocken CHM; Delves MJ; Leroy D; Fidock DA; Waterson D; Street LJ; Chibale K
    Sci Transl Med; 2017 Apr; 9(387):. PubMed ID: 28446690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronobiology and chronotherapy of malaria: investigations with murine malaria models.
    Landau I; Caillard V; Beaute-Lafitte A; Chabaud A
    Parassitologia; 1993 Jul; 35 Suppl():55-7. PubMed ID: 8233614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Host-cell invasion by malaria parasites: insights from Plasmodium and Toxoplasma.
    Baum J; Gilberger TW; Frischknecht F; Meissner M
    Trends Parasitol; 2008 Dec; 24(12):557-63. PubMed ID: 18835222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The schizonticidal activity of hydroxynaphthoquinones against Plasmodium berghei infections in mice.
    Berberian DA; Slighter RG
    J Parasitol; 1968 Oct; 54(5):999-1005. PubMed ID: 5757682
    [No Abstract]   [Full Text] [Related]  

  • 38. [Malaria--treatment].
    Löscher T; Hoelscher M; Nothdurft HD
    Dtsch Med Wochenschr; 2003 Jun; 128(23):1294-6. PubMed ID: 12789640
    [No Abstract]   [Full Text] [Related]  

  • 39. Synthesis and evaluation of sulfonylurea derivatives as novel antimalarials.
    León C; Rodrigues J; Gamboa de Domínguez N; Charris J; Gut J; Rosenthal PJ; Domínguez JN
    Eur J Med Chem; 2007 Jun; 42(6):735-42. PubMed ID: 17321641
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New 6-aminoquinolines with antimalarial activity. Test results on schizontocidal and causalprophylactic effects in rodent- and avian malaria (Plasmodium vinckei, P. berghei and P. cathemerium)].
    Fink E; Nickel P; Dann O
    Arzneimittelforschung; 1970 Nov; 20(11):1775-7. PubMed ID: 5536991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.